Knight Therapeutics Inc. (KHTRF) Financials
KHTRF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 781.2 million | 215.2 million |
| Dec. 31, 2025 | 762.6 million | 203.4 million |
| Sept. 30, 2025 | 754.1 million | 202.7 million |
| June 30, 2025 | 762.8 million | 202.0 million |
KHTRF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | 26.7 million | ? |
| Dec. 31, 2025 | 24.6 million | 2.1 million |
| Sept. 30, 2025 | 7.3 million | ? |
| June 30, 2025 | -3.6 million | 1.9 million |
KHTRF Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| March 31, 2026 | 9.5 million |
| Dec. 31, 2025 | 6.5 million |
| Sept. 30, 2025 | -2.7 million |
| June 30, 2025 | -9.3 million |
KHTRF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 91.5 million | 29.3 million | 5.3 million |
| Dec. 31, 2025 | 69.4 million | 37.3 million | 4.8 million |
| Sept. 30, 2025 | 68.7 million | 56.6 million | 4.3 million |
| June 30, 2025 | 85.6 million | 57.9 million | 5.2 million |
KHTRF Shares Outstanding
KHTRF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 2.4 million | 6.8 million | 24.8 million | - |
| Dec. 31, 2025 | 368047 | 6.7 million | 25.8 million | - |
| Sept. 30, 2025 | 294867 | 6.3 million | 22.3 million | - |
| June 30, 2025 | 18.5 million | 4.6 million | 23.1 million | 11.5 million |
KHTRF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 106.7 million | 67.6 million |
| Dec. 31, 2025 | 97.0 million | 59.9 million |
| Sept. 30, 2025 | 87.4 million | 58.4 million |
| June 30, 2025 | 78.9 million | 46.0 million |
KHTRF
Price: $6.11
52 week price:
Earnings Per Share: 0.04 USD
P/E Ratio: 158.75
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 587.2 million